Fundraising Fox
Manus Bio
Augusta, US · Founded 2011 · Delaware corporation · 189 employees on LinkedIn · 11 known investors
Find your way into Manus Bio
Sign up to see every warm intro you have to Manus Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Manus Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Manus Bio uses industrial biotechnology and engineered microbial cell factories to produce "BioAlternatives" — sustainable versions of molecules normally sourced from petrochemicals, agriculture, or animal husbandry — and offers a scale-up platform covering cell factory design through biomanufacturing. Its products include sweeteners and flavor/fragrance ingredients supplied to food and consumer goods companies such as Tate & Lyle and Givaudan.
Founders & leadership
Manus Bio was founded in 2011 by Aji Parayil and Greg Stephanopoulos.
Board
Investors · 11
How we know: av.vc · Not right? Tell us
How we know: Civilization Ventures Management, Llc's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Energy Impact Partners's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: NXT Ventures's portfolio page · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
How we know: Rhapsody Venture Partners's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$118M disclosed across 6 rounds · 2016–2024
▶$11.3MraisedMay 2024 · 6 investors · OtherRule 506(b)
- Ajikumar Parayil KumaranDirector, Executive Officer
- Rick GersonDirector
- Alena IvashenkaDirector
- Julio A. Ruiz CalderonExecutive Officer
- Michael CarlosDirector
- Jean NehmeDirector
- Offering amount
- $11.3M
- Amount sold
- $11.3M
- First sale
- Apr 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$21.2MraisedMay 2023 · 14 investors · OtherRule 506(b)
- John NehmeDirector
- Michael CarlosDirector
- Jeremiah HuxExecutive Officer
- Ajikumar ParayilExecutive Officer, Director
- Rick GersonDirector
- Alena IvashenkaDirector
- Offering amount
- $22.3M
- Amount sold
- $21.2M
- First sale
- Aug 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$66.2MraisedNov 2020 · 27 investors · OtherRule 506(b)
- Gregory StephanopoulosDirector
- Zanna McFersonDirector
- Raymond ChangDirector
- Bryon AlsbergDirector
- Michael CarlosDirector
- Colin GoundenDirector
- Christine SantosExecutive Officer
- Paul BoniExecutive Officer
- Jeff AndersonExecutive Officer
- Ajikumar ParayilExecutive Officer, Director
- Offering amount
- $80M
- Amount sold
- $66.2M
- First sale
- Apr 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$10MraisedJul 2018 · 15 investors · OtherRule 506(b)
- Paul BoniExecutive Officer
- Zanna McFersonDirector
- Michael CarlosDirector
- Gregory StephanopoulosDirector
- Colin GoundenDirector
- Raymond ChangDirector
- Ajikumar ParayilExecutive Officer, Director
- Bryon AlsbergDirector
- Christine SantosExecutive Officer
- Jeff AndersonExecutive Officer
- Offering amount
- $12M
- Amount sold
- $10M
- First sale
- Jun 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$9.1MraisedDec 2017 · 24 investors · BiotechnologyRule 506(b)
- Byron AlsbergDirector
- Michael CarlosDirector
- Colin GoundenDirector
- Carsten BoersDirector
- Gregory StephanopoulosDirector
- Ajikumar ParayilExecutive Officer, Director
- Offering amount
- $10M
- Amount sold
- $9.1M
- First sale
- Aug 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$300KraisedOct 2016 · 2 investors · BiotechnologyRule 506(b)
- Richard GoldsteinDirector
- Jason WhaleyDirector
- Carsten BoersDirector
- Ajikumar ParayilExecutive Officer, Director
- Gregory StephanopoulosDirector
- Offering amount
- $3M
- Amount sold
- $300K
- First sale
- Sep 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
Companies working in the same space as Manus Bio.
Non-dilutive funding · 6 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| Department of Agriculture (USDA) | Phase I | 2018 | $99K |
| National Science Foundation | Phase II | 2017 | $600K |
| National Science Foundation | Phase I | 2016 | $225K |
| National Science Foundation | Phase ISTTR | 2013 | $225K |
| National Science Foundation | Phase I | 2013 | $150K |
| National Science Foundation | Phase I | 2012 | $150K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Manus Bio do?
- Manus Bio uses industrial biotechnology and engineered microbial cell factories to produce "BioAlternatives" — sustainable versions of molecules normally sourced from petrochemicals, agriculture, or animal husbandry — and offers a scale-up platform covering cell factory design through biomanufacturing. Its products include sweeteners and flavor/fragrance ingredients supplied to food and consumer goods companies such as Tate & Lyle and Givaudan.
- Who founded Manus Bio?
- Manus Bio was founded by Aji Parayil, Greg Stephanopoulos in 2011.
- Who are Manus Bio's investors?
- Manus Bio's investors include +ND Capital, Alumni Ventures, Civilization Ventures Management, Llc, Energy Impact Partners, Liebenthal Ventures, Nelstone Ventures, NXT Ventures, Prefix Capital and 3 more.
- How much funding has Manus Bio raised?
- Manus Bio has disclosed $118M raised across 6 rounds.
- Where is Manus Bio headquartered?
- Manus Bio is headquartered in Augusta, US.